Predict your next investment

Holding Company

See what CB Insights has to offer

Investments

2

About MI3

MI3 is an investment holding company based in Luxembourg.

MI3 Headquarter Location

Luxembourg

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest MI3 News

Relevium to Present at Mi3 Online Investor Webinar

Apr 20, 2020

| Source: Relevium Technologies Inc MONTREAL, April 20, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTC:“ RLLVF ” and Frankfurt: “ 6BX ”) (the “Company” or “Relevium”), is pleased to announce that the company will be presenting at the Mi3 Investor and Broker Video Conference this Friday April 24th at 12:00PM Eastern Time. Aurelio Useche, CEO will discuss the “new normal” in terms of social interactions, in particular as we prepare to resume economic activities. The CEO will also be discussing the underlying opportunities for Relevium and its newly launched CleanCare line of products, including hand sanitizers and air cleaning systems for residential and office use. Investors interested in attending the webinar on April 24th at 12:00PM EST may do so through the zoom portal using the link below: About Relevium Technologies Relevium is a publicly traded Company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operation of brands and businesses in the health and wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly owned subsidiaries: BGX E-Health LLC (BGX), based in Orlando, Florida, markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe. Relevium’s premium brands are sold at some of the world’s largest retailers including Walmart.com and Amazon.com. Biocannabix Health Corporation (BCX), based in Montreal, Quebec, is a biopharma nutraceutical Company focused on delivering pediatric endo-medicinal nutraceuticals for cannabinoid therapy. Cautionary Note Regarding Forward-Looking Statements This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will be able to apply for and ultimately obtain an ACMPR licence, the proposed business of Biocannabix will develop as anticipated, that the Company will raise sufficient funds to develop the Biocannabix business, and that the Company will obtain all requisite regulatory approvals. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed business developments may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor. On Behalf of the Board of Directors RELEVIUM TECHNOLOGIES INC.

MI3 Investments

2 Investments

MI3 has made 2 investments. Their latest investment was in Bistrot Bagatelle as part of their Private Equity on April 4, 2019.

CBI Logo

MI3 Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/26/2019

Private Equity

Bistrot Bagatelle

$19.75M

Yes

1

3/29/2017

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/26/2019

3/29/2017

Round

Private Equity

Series A

Company

Bistrot Bagatelle

Subscribe to see more

Amount

$19.75M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.